Nad
NAD
COSYNE 2025
The COSYNE 2025 conference was held in Montreal with post-conference workshops in Mont-Tremblant, continuing to provide a premier forum for computational and systems neuroscience. Attendees exchanged cutting-edge research in a single-track main meeting and in-depth specialized workshops, reflecting Cosyne’s mission to understand how neural systems function:contentReference[oaicite:6]{index=6}:contentReference[oaicite:7]{index=7}.
ALBA webinar series - Breaking down the ivory tower: Ep. 3 Donna Rose Addis
With this webinar series, the ALBA Disability & Accessibility Working Group aims to bring down the ivory tower of ableism among the brain research community, one extraordinary neuroscientist at a time. These webinars give a platform to scientists with disabilities across the globe and neuroscience disciplines, while reflecting on how to promote inclusive working environments and accessibility to research. For this 3rd episode, Dr. Donna Rose Addis (Rotman Research Institute, Baycrest & University of Toronto, Canada) will talk about her research and experience.
Rodents to Investigate the Neural Basis of Audiovisual Temporal Processing and Perception
To form a coherent perception of the world around us, we are constantly processing and integrating sensory information from multiple modalities. In fact, when auditory and visual stimuli occur within ~100 ms of each other, individuals tend to perceive the stimuli as a single event, even though they occurred separately. In recent years, our lab, and others, have developed rat models of audiovisual temporal perception using behavioural tasks such as temporal order judgments (TOJs) and synchrony judgments (SJs). While these rodent models demonstrate metrics that are consistent with humans (e.g., perceived simultaneity, temporal acuity), we have sought to confirm whether rodents demonstrate the hallmarks of audiovisual temporal perception, such as predictable shifts in their perception based on experience and sensitivity to alterations in neurochemistry. Ultimately, our findings indicate that rats serve as an excellent model to study the neural mechanisms underlying audiovisual temporal perception, which to date remains relativity unknown. Using our validated translational audiovisual behavioural tasks, in combination with optogenetics, neuropharmacology and in vivo electrophysiology, we aim to uncover the mechanisms by which inhibitory neurotransmission and top-down circuits finely control ones’ perception. This research will significantly advance our understanding of the neuronal circuitry underlying audiovisual temporal perception, and will be the first to establish the role of interneurons in regulating the synchronized neural activity that is thought to contribute to the precise binding of audiovisual stimuli.
Sex hormone regulation of neural gene expression
Gonadal steroid hormones are the principal drivers of sex-variable biology in vertebrates. In the brain, estrogen (17β-estradiol) establishes neural sex differences in many species and modulates mood, behavior, and energy balance in adulthood. To understand the diverse effects of estradiol on the brain, we profiled the genomic binding of estrogen receptor alpha (ERα), providing the first picture of the neural actions of any gonadal hormone receptor. To relate ERα target genes to brain sex differences we assessed gene expression and chromatin accessibility in the posterior bed nucleus of the stria terminalis (BNSTp), a sexually dimorphic node in limbic circuitry that underlies sex-differential social behaviors such as aggression and parenting. In adult animals we observe that levels of ERα are predictive of the extent of sex-variable gene expression, and that these sex differences are a dynamic readout of acute hormonal state. In neonates we find that transient ERα recruitment at birth leads to persistent chromatin opening and male-biased gene expression, demonstrating a true epigenetic mechanism for brain sexual differentiation. Collectively, our findings demonstrate that sex differences in gene expression in the brain are a readout of state-dependent hormone receptor actions, rather than other factors such as sex chromosomes. We anticipate that the ERα targets we have found will contribute to established sex differences in the incidence and etiology of neurological and psychiatric disorders.
COSYNE 2023
The COSYNE 2023 conference provided an inclusive forum for exchanging experimental and theoretical approaches to problems in systems neuroscience, continuing the tradition of bringing together the computational neuroscience community:contentReference[oaicite:5]{index=5}. The main meeting was held in Montreal followed by post-conference workshops in Mont-Tremblant, fostering intensive discussions and collaboration.
Programmed axon death: from animal models into human disease
Programmed axon death is a widespread and completely preventable mechanism in injury and disease. Mouse and Drosophila studies define a molecular pathway involving activation of SARM1 NA Dase and its prevention by NAD synthesising enzyme NMNAT2 . Loss of axonal NMNAT2 causes its substrate, NMN , to accumulate and activate SARM1 , driving loss of NAD and changes in ATP , ROS and calcium. Animal models caused by genetic mutation, toxins, viruses or metabolic defects can be alleviated by blocking programmed axon death, for example models of CMT1B , chemotherapy-induced peripheral neuropathy (CIPN), rabies and diabetic peripheral neuropathy (DPN). The perinatal lethality of NMNAT2 null mice is completely rescued, restoring a normal, healthy lifespan. Animal models lack the genetic and environmental diversity present in human populations and this is problematic for modelling gene-environment combinations, for example in CIPN and DPN , and identifying rare, pathogenic mutations. Instead, by testing human gene variants in WGS datasets for loss- and gain-of-function, we identified enrichment of rare SARM1 gain-of-function variants in sporadic ALS , despite previous negative findings in SOD1 transgenic mice. We have shown in mice that heterozygous SARM1 loss-of-function is protective from a range of axonal stresses and that naturally-occurring SARM1 loss-of-function alleles are present in human populations. This enables new approaches to identify disorders where blocking SARM1 may be therapeutically useful, and the existence of two dominant negative human variants in healthy adults is some of the best evidence available that drugs blocking SARM1 are likely to be safe. Further loss- and gain-of-function variants in SARM1 and NMNAT2 are being identified and used to extend and strengthen the evidence of association with neurological disorders. We aim to identify diseases, and specific patients, in whom SARM1 -blocking drugs are most likely to be effective.
Bridging the gap from research to clinical decision making in epilepsy neuromodulation; How to become an integral part of the functional neurosurgery team as a radiologist
On Wednesday, November 30th, at noon ET / 6PM CET, we will host Alexandre Boutet and Erik H. Middlebrooks. Alexandre Boutet, MD, PhD, is a neuroradiology fellow at the University of Toronto, and will tell us about “How to become an integral part of the functional neurosurgery team as a radiologist”. Erik H. Middlebrooks, MD, is a Professor and Consultant of Neuroradiology and Neurosurgery and the Neuroradiology Program Director at Mayo Clinic. Beside his scientific presentation about “Bridging the Gap from Research to Clinical Decision Making in Epilepsy Neuromodulation”, he will also give us a glimpse at the “Person behind the science”. The talks will be followed by a shared discussion. You can register via talks.stimulatingbrains.org to receive the (free) Zoom link!
Biological and experience-based trajectories in adolescent brain and cognitive development
Adolescent development is not only shaped by the mere passing of time and accumulating experience, but it also depends on pubertal timing and the cascade of maturational processes orchestrated by gonadal hormones. Although individual variability in puberty onset confounds adolescent studies, it has not been efficiently controlled for. Here we introduce ultrasonic bone age assessment to estimate biological maturity and disentangle the independent effects of chronological and biological age on adolescent cognitive abilities, emotional development, and brain maturation. Comparing cognitive performance of participants with different skeletal maturity we uncover the impact of biological age on both IQ and specific abilities. With respect to emotional development, we find narrow windows of highest vulnerability determined by biological age. In terms of neural development, we focus on the relevance of neural states unrelated to sensory stimulation, such as cortical activity during sleep and resting states, and we uncover a novel anterior-to-posterior pattern of human brain maturation. Based on our findings, bone age is a promising biomarker of adolescent maturity.
Hypothalamic episode generators underlying the neural control of fertility
The hypothalamus controls diverse homeostatic functions including fertility. Neural episode generators are required to drive the intermittent pulsatile and surge profiles of reproductive hormone secretion that control gonadal function. Studies in genetic mouse models have been fundamental in defining the neural circuits forming these central pattern generators and the full range of in vitro and in vivo optogenetic and chemogenetic methodologies have enabled investigation into their mechanism of action. The seminar will outline studies defining the hypothalamic “GnRH pulse generator network” and current understanding of its operation to drive pulsatile hormone secretion.
Pitch and Time Interact in Auditory Perception
Research into pitch perception and time perception has typically treated the two as independent processes. However, previous studies of music and speech perception have suggested that pitch and timing information may be processed in an integrated manner, such that the pitch of an auditory stimulus can influence a person’s perception, expectation, and memory of its duration and tempo. Typically, higher-pitched sounds are perceived as faster and longer in duration than lower-pitched sounds with identical timing. We conducted a series of experiments to better understand the limits of this pitch-time integrality. Across several experiments, we tested whether the higher-equals-faster illusion generalizes across the broader frequency range of human hearing by asking participants to compare the tempo of a repeating tone played in one of six octaves to a metronomic standard. When participants heard tones from all six octaves, we consistently found an inverted U-shaped effect of the tone’s pitch height, such that perceived tempo peaked between A4 (440 Hz) and A5 (880 Hz) and decreased at lower and higher octaves. However, we found that the decrease in perceived tempo at extremely high octaves could be abolished by exposing participants to high-pitched tones only, suggesting that pitch-induced timing biases are context sensitive. We additionally tested how the timing of an auditory stimulus influences the perception of its pitch, using a pitch discrimination task in which probe tones occurred early, late, or on the beat within a rhythmic context. Probe timing strongly biased participants to rate later tones as lower in pitch than earlier tones. Together, these results suggest that pitch and time exert a bidirectional influence on one another, providing evidence for integrated processing of pitch and timing information in auditory perception. Identifying the mechanisms behind this pitch-time interaction will be critical for integrating current models of pitch and tempo processing.
Controlling the present while planning the future: How the brain learns and produces fast motor sequences
Motor sequencing is one of the fundamental components of human motor skill. In this talk I will show evidence that the fast and smooth production of motor sequences relies on the ability to plan upcoming movements while simultaneously controlling the ongoing movement. I will argue that this ability relies heavily on planning-related areas in premotor and parietal cortex.
Pynapple: a light-weight python package for neural data analysis - webinar + tutorial
In systems neuroscience, datasets are multimodal and include data-streams of various origins: multichannel electrophysiology, 1- or 2-p calcium imaging, behavior, etc. Often, the exact nature of data streams are unique to each lab, if not each project. Analyzing these datasets in an efficient and open way is crucial for collaboration and reproducibility. In this combined webinar and tutorial, Adrien Peyrache and Guillaume Viejo will present Pynapple, a Python-based data analysis pipeline for systems neuroscience. Designed for flexibility and versatility, Pynapple allows users to perform cross-modal neural data analysis via a common programming approach which facilitates easy sharing of both analysis code and data.
Pynapple: a light-weight python package for neural data analysis - webinar + tutorial
In systems neuroscience, datasets are multimodal and include data-streams of various origins: multichannel electrophysiology, 1- or 2-p calcium imaging, behavior, etc. Often, the exact nature of data streams are unique to each lab, if not each project. Analyzing these datasets in an efficient and open way is crucial for collaboration and reproducibility. In this combined webinar and tutorial, Adrien Peyrache and Guillaume Viejo will present Pynapple, a Python-based data analysis pipeline for systems neuroscience. Designed for flexibility and versatility, Pynapple allows users to perform cross-modal neural data analysis via a common programming approach which facilitates easy sharing of both analysis code and data.
Using eye tracking to investigate neural circuits in health and disease
The 15th David Smith Lecture in Anatomical Neuropharmacology: Professor Tim Bliss, "Memories of long term potentiation
The David Smith Lectures in Anatomical Neuropharmacology, Part of the 'Pharmacology, Anatomical Neuropharmacology and Drug Discovery Seminars Series', Department of Pharmacology, University of Oxford. The 15th David Smith Award Lecture in Anatomical Neuropharmacology will be delivered by Professor Tim Bliss, Visiting Professor at UCL and the Frontier Institutes of Science and Technology, Xi’an Jiaotong University, China, and is hosted by Professor Nigel Emptage. This award lecture was set up to celebrate the vision of Professor A David Smith, namely, that explanations of the action of drugs on the brain requires the definition of neuronal circuits, the location and interactions of molecules. Tim Bliss gained his PhD at McGill University in Canada. He joined the MRC National Institute for Medical Research in Mill Hill, London in 1967, where he remained throughout his career. His work with Terje Lømo in the late 1960’s established the phenomenon of long-term potentiation (LTP) as the dominant synaptic model of how the mammalian brain stores memories. He was elected as a Fellow of the Royal Society in 1994 and is a founding fellow of the Academy of Medical Sciences. He shared the Bristol Myers Squibb award for Neuroscience with Eric Kandel in 1991, the Ipsen Prize for Neural Plasticity with Richard Morris and Yadin Dudai in 2013. In May 2012 he gave the annual Croonian Lecture at the Royal Society on ‘The Mechanics of Memory’. In 2016 Tim, with Graham Collingridge and Richard Morris shared the Brain Prize, one of the world's most coveted science prizes. Abstract: In 1966 there appeared in Acta Physiologica Scandinavica an abstract of a talk given by Terje Lømo, a PhD student in Per Andersen’s laboratory at the University of Oslo. In it Lømo described the long-lasting potentiation of synaptic responses in the dentate gyrus of the anaesthetised rabbit that followed repeated episodes of 10-20Hz stimulation of the perforant path. Thus, heralded and almost entirely unnoticed, one of the most consequential discoveries of 20th century neuroscience was ushered into the world. Two years later I arrived in Oslo as a visiting post-doc from the National Institute for Medical Research in Mill Hill, London. In this talk I recall the events that led us to embark on a systematic reinvestigation of the phenomenon now known as long-term potentiation (LTP) and will then go on to describe the discoveries and controversies that enlivened the early decades of research into synaptic plasticity in the mammalian brain. I will end with an observer’s view of the current state of research in the field, and what we might expect from it in the future.
Untitled Seminar
Emilia Favuzzi (USA): Artisans of Brain Wiring: GABA-Receptive Microglia Selectively Sculpt Inhibitory Circuits; Ewoud Schmidt (USA): Humanizing the mouse brain: reorganizing cortical circuits through modified synaptic development; Tracy Bale (USA): Trophoblast mechanisms key in regulating neurodevelopment Anastassia Voronova (Canada): Regulation of neural stem cell fates by neuronal ligands
The Role of Cerebrovascular Pathology in Aging and Neurodegenerative Disease Populations
Late-life cognitive impairment and dementia are heterogeneous and multifactorial conditions driven by a combination of genetic, vascular, and lifestyle-related factors. More than 75% of patients with dementia have evidence of cerebrovascular pathology at autopsy. Cerebrovascular disease lesions can be detected on structural MRI and used as biomarkers to determine the extent of cerebrovascular pathology. These biomarkers are associated with cognitive difficulties and increase the risk of dementia for the same level of neurodegenerative pathology. Given that some of the risk factors for cerebrovascular disease are potentially modifiable, identifying the role of cerebrovascular pathology in aging and neurodegenerative disease populations opens a window for prevention of cognitive decline and dementia.
Towards a More Authentic Vision of the (multi)Coding Potential of RNA
Ten of thousands of open reading frames (ORFs) are hidden within transcripts. They have eluded annotations because they are either small or within unsuspected locations. These are named alternative ORFs (altORFs) or small ORFs and have recently been highlighted by innovative proteogenomic approaches, such as our OpenProt resource, revealing their existence and implications in biological functions. Due to the absence of altORFs from annotations, pathogenic mutations within these are being ignored. I will discuss our latest progress on the re-analysis of large-scale proteomics datasets to improve our knowledge of proteomic diversity, and the functional characterization of a second protein coded by the FUS gene. Finally, I will explain the need to map the coding potential of the transcriptome using artificial intelligence rather than with conventional annotations that do not capture the full translational activity of ribosomes.
From bench to clinic – Translating fundamental neuroscience into real-life healthcare practices, and developing nationally recognised life science companies
Dr. Ryan C.N. D’Arcy is a Canadian neuroscientist, researcher, innovator and entrepreneur. Dr. D'Arcy co-founded HealthTech Connex Inc. and serves as President and Chief Scientific Officer. HealthTech Connex translates neuroscience advances into health technology breakthroughs. D'Arcy is most known for coining the term "brain vital signs" and for leading the research and development of the brain vital signs framework. Dr. D’Arcy also holds a BC Leadership Chair in Medical Technology, is a full Professor at Simon Fraser University, and a member of the DM Centre for Brain Health at the University of British Columbia. He has published more than 260 academic works, attracted more than $85 Million CAD in competitive research and innovation funding, and been recognized through numerous awards and distinctions. Please join us for an exciting virtual talk with Dr. D'Arcy who will speak on some of the current research he is involved in, how he is translating this research into real-life applications, and the development of HealthTech Connects Inc.
Second National Training Course on Sleep Medicine
Many patients presenting to neurology either have primary sleep disorders or suffer from sleep comorbidity. Knowledge on the diagnosis, differential diagnostic considerations, and management of these disorders is therefore mandatory for the general neurologist. This comprehensive course may serve to fulfill part of the preparation requirements for trainees seeking to complete the Royal College Examinations in Neurology. This training course is for R4 and R5 residents in Canadian neurology training programs as well as neurologists.
Retinoblastoma: Canadian global leadership
NAD+ metabolism in axon and neurodegeneration (from a fly’s perspective)
Analyzing Retinal Disease Using Electron Microscopic Connectomics
John DowlingJohn E. Dowling received his AB and PhD from Harvard University. He taught in the Biology Department at Harvard from 1961 to 1964, first as an Instructor, then as assistant professor. In 1964 he moved to Johns Hopkins University, where he held an appointment as associate professor of Ophthalmology and Biophysics. He returned to Harvard as professor of Biology in 1971, was the Maria Moors Cabot Professor of Natural Sciences from 1971-2001, Harvard College professor from 1999-2004 and is presently the Gordon and Llura Gund Professor of Neurosciences. Dowling was chairman of the Biology Department at Harvard from 1975 to 1978 and served as associate dean of the faculty of Arts and Sciences from 1980 to 1984. He was Master of Leverett House at Harvard from 1981-1998 and currently serves as president of the Corporation of The Marine Biological Laboratory in Woods Hole. He is a Fellow of the American Academy of Arts and Sciences, a member of the National Academy of Sciences and a member of the American Philosophical Society. Awards that Dowling received include the Friedenwald Medal from the Association of Research in Ophthalmology and Vision in 1970, the Annual Award of the New England Ophthalmological Society in 1979, the Retinal Research Foundation Award for Retinal Research in 1981, an Alcon Vision Research Recognition Award in 1986, a National Eye Institute's MERIT award in 1987, the Von Sallman Prize in 1992, The Helen Keller Prize for Vision Research in 2000 and the Llura Ligget Gund Award for Lifetime Achievement and Recognition of Contribution to the Foundation Fighting Blindness in 2001. He was granted an honorary MD degree by the University of Lund (Sweden) in 1982 and an honorary Doctor of Laws degree from Dalhousie University (Canada) in 2012. Dowling's research interests have focused on the vertebrate retina as a model piece of the brain. He and his collaborators have long been interested in the functional organization of the retina, studying its synaptic organization, the electrical responses of the retinal neurons, and the mechanisms underlying neurotransmission and neuromodulation in the retina. Dowling became interested in zebrafish as a system in which one could explore the development and genetics of the vertebrate retina about 20 years ago. Part of his research team has focused on retinal development in zebrafish and the role of retinoic acid in early eye and photoreceptor development. A second group has developed behavioral tests to isolate mutations, both recessive and dominant, specific to the visual system.
Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease
Alzheimer’s disease is the most common age-related neurodegenerative disorder. Familial forms of Alzheimer’s disease associated with the accumulation of a toxic form of amyloid-β (Aβ) peptides are linked to mitochondrial impairment. The coenzyme nicotinamide adenine dinucleotide (NAD+) is essential for both mitochondrial bioenergetics and nuclear DNA repair through NAD+-consuming poly (ADP-ribose) polymerases (PARPs). Here, we analysed the metabolomic changes in flies over-expressing Aβ and showed a decrease of metabolites associated with nicotinate and nicotinamide metabolism, which is critical for mitochondrial function in neurons. We show that increasing the bioavailability of NAD+ protects against Aβ toxicity. Pharmacological supplementation using NAM, a form of vitamin B that acts as a precursor for NAD+ or a genetic mutation of PARP rescues mitochondrial defects, protects neurons against degeneration and reduces behavioural impairments in a fly model of Alzheimer’s disease. Next, we looked at links between PARP polymorphisms and vitamin B intake in patients with Alzheimer’s disease. We show that polymorphisms in the human PARP1 gene or the intake of vitamin B, are associated with a decrease in the risk and severity of Alzheimer’s disease. We suggest that enhancing the availability of NAD+ by either vitamin B supplements or the inhibition of NAD+-dependent enzymes, such as PARPs are potential therapies for Alzheimer’s disease.
Neural correlates of cognitive control across the adult lifespan
Cognitive control involves the flexible allocation of mental resources during goal-directed behaviour and comprises three correlated but distinct domains—inhibition, task shifting, and working memory. Healthy ageing is characterised by reduced cognitive control. Professor Cheryl Grady and her team have been studying the influence of age differences in large-scale brain networks on the three control processes in a sample of adults from 20 to 86 years of age. In this webinar, Professor Cheryl Grady will describe three aspects of this work: 1) age-related dedifferentiation and reconfiguration of brain networks across the sub-domains 2) individual differences in the relation of task-related activity to age, structural integrity and task performance for each sub-domain 3) modulation of brain signal variability as a function of cognitive load and age during working memory. This research highlights the reduction in dynamic range of network activity that occurs with ageing and how this contributes to age differences in cognitive control. Cheryl Grady is a senior scientist at the Rotman Research Institute at Baycrest, and Professor in the departments of Psychiatry and Psychology at the University of Toronto. She held the Canada Research Chair in Neurocognitive Aging from 2005-2018 and was elected as a Fellow of the Royal Society of Canada in 2019. Her research uses MRI to determine the role of brain network connectivity in cognitive ageing.
Innate immune response in brain pathologies: Lost in translation?
Inflammation is a key component of the innate immune response. Primarily designed to remove noxious agents and limit their detrimental effects, the prolonged and/or inappropriately scaled innate immune response may be detrimental to the host and lead to a chronic disease. Indeed, there is increasing evidence suggesting that a chronic deregulation of immunity may represent one of the key elements in the pathobiology of many brain disorders. Microglia are the principal immune cells of the brain. The consensus today is that once activated microglia/macrophages can acquire a wide repertoire of profiles ranging from the classical pro-inflammatory to alternative and protective phenotypes. Recently, we described a novel ribosome-based regulatory mechanism/checkpoint that controls innate immune gene translation and microglial activation involving RNA binding protein SRSF3. Here we will discuss the implications of SRSF3 and other endogenous immune regulators in deregulation of immunity observed in different models of brain pathologies. Furthermore, we will discuss whether targeting SRSF3 and mRNA translation may open novel avenues for therapeutic modulation of immune response in the brain.
Herbert Jasper Lecture
There is a long-standing tension between the notion that the hippocampal formation is essentially a spatial mapping system, and the notion that it plays an essential role in the establishment of episodic memory and the consolidation of such memory into structured knowledge about the world. One theory that resolves this tension is the notion that the hippocampus generates rather arbitrary 'index' codes that serve initially to link attributes of episodic memories that are stored in widely dispersed and only weakly connected neocortical modules. I will show how an essentially 'spatial' coding mechanism, with some tweaks, provides an ideal indexing system and discuss the neural coding strategies that the hippocampus apparently uses to overcome some biological constraints affecting the possibility of shipping the index code out widely to the neocortex. Finally, I will present new data suggesting that the hippocampal index code is indeed transferred to layer II-III of the neocortex.
Neural dynamics underlying temporal inference
Animals possess the ability to effortlessly and precisely time their actions even though information received from the world is often ambiguous and is inadvertently transformed as it passes through the nervous system. With such uncertainty pervading through our nervous systems, we could expect that much of human and animal behavior relies on inference that incorporates an important additional source of information, prior knowledge of the environment. These concepts have long been studied under the framework of Bayesian inference with substantial corroboration over the last decade that human time perception is consistent with such models. We, however, know little about the neural mechanisms that enable Bayesian signatures to emerge in temporal perception. I will present our work on three facets of this problem, how Bayesian estimates are encoded in neural populations, how these estimates are used to generate time intervals, and how prior knowledge for these tasks is acquired and optimized by neural circuits. We trained monkeys to perform an interval reproduction task and found their behavior to be consistent with Bayesian inference. Using insights from electrophysiology and in silico models, we propose a mechanism by which cortical populations encode Bayesian estimates and utilize them to generate time intervals. Thereafter, I will present a circuit model for how temporal priors can be acquired by cerebellar machinery leading to estimates consistent with Bayesian theory. Based on electrophysiology and anatomy experiments in rodents, I will provide some support for this model. Overall, these findings attempt to bridge insights from normative frameworks of Bayesian inference with potential neural implementations for the acquisition, estimation, and production of timing behaviors.
Spatiotemporal patterns of neocortical activity around hippocampal sharp-wave ripples
Neocortical-hippocampal interactions during off-line periods such as slow-wave sleep are implicated in memory processing. In particular, recent memory traces are replayed in hippocampus during some sharp-wave ripple (SWR) events, and these replay events are positively correlated with neocortical memory trace reactivation. A prevalent model is that SWR arise ‘spontaneously’ in CA3 and propagate recent memory ‘indices’ outward to the neocortex to enable memory consolidation there; however, the spatiotemporal distribution of neocortical activation relative to SWR is incompletely understood. We used wide-field optical imaging to study voltage and glutamate release transients in dorsal neocortex in relation to CA1 multiunit activity (MUA) and SWR of sleeping and urethane anesthetized mice. Modulation of voltage and glutamate release signals in relation to SWRs varied across superficial neocortical regions, and it was largest in posteromedial regions surrounding retrosplenial cortex (RSC), which receives strong hippocampal output connections. Activity tended to spread sequentially from more medial towards more lateral regions. Contrary to the unidirectional hypothesis, activation exhibited a continuum of timing relative to SWRs, varying from neocortex leading to neocortex lagging the SWRs (± ~250 msec). The timing continuum was correlated with the skewness of peri-SWR hippocampal MUA and with a tendency for some SWR to occur in clusters. Thus, contrary to the model in which SWRs arise spontaneously in hippocampus, neocortical activation often precedes SWRs and may thus constitute a trigger event in which neocortical information seeds associative reactivation of hippocampal ‘indices’.
The effect of gravity on the perception of distance and self-motion
Gravity is a constant in our lives. It provides an internalized reference to which all other perceptions are related. We can experimentally manipulate the relationship between physical gravity with other cues to the direction of “up” using virtual reality - with either HMDs or specially built tilting environments - to explore how gravity contributes to perceptual judgements. The effect of gravity can also be cancelled by running experiments on the International Space Station in low Earth orbit. Changing orientation relative to gravity - or even just perceived orientation – affects your perception of how far away things are (they appear closer when supine or prone). Cancelling gravity altogether has a similar effect. Changing orientation also affects how much visual motion is needed to perceive a particular travel distance (you need less when supine or prone). Adapting to zero gravity has the opposite effect (you need more). These results will be discussed in terms of their practical consequences and the multisensory processes involved, in particular the response to visual-vestibular conflict.
Sleep and the gut
Sleep is generally associated with the brain but poor sleep impacts the entire body - many diseases are caused or exacerbated by sleep loss. Our work is uncovering ways in which sleep and the body interact. We found a special, two-way relationship between sleep and the gut: the gut is uniquely impacted by sleep loss, and it actively controls sleep quality. These findings could help us understand the origins of sleep as well as develop strategies to offset the negative consequences of inadequate sleep.
The origin of symmetry: how animals orient themselves in space
Making Memories in Mice
Sensory brain responses alterations as translational markers for SynGAP1 haploinsufficiency
Alteraciones en los patrones electrofisiológicos subyacentes a la percepción sensorial y su uso como biomarcadores de Syngap1
Algorithmic advances in face matching: Stability of tests in atypical groups
Face matching tests have traditionally been developed to assess human face perception in the neurotypical range, but methods that underlie their development often make it difficult for these measures to be applied in atypical populations (developmental prosopagnosics, super recognizers) due to unadjusted difficulty. We have recently presented the development of the Oxford Face Matching Test, a measure that bases individual item-difficulty on algorithmically derived similarity of presented stimuli. The measure seems useful as it can be given online or in-laboratory, has good discriminability and high test-retest reliability in the neurotypical groups. In addition, it has good validity in separating atypical groups at either of the spectrum ends. In this talk, I examine the stability of the OFMT and other traditionally used measures in atypical groups. On top of the theoretical significance of determining whether reliability of tests is equivalent in atypical population, this is an important question because of the practical concerns of retesting the same participants across different lab groups. Theoretical and practical implications for further test development and data sharing are discussed.
Toward an understanding of the impact of prenatal exposure to environmental contaminants on brain development
The risks of in utero and early exposure to environmental contaminants, such as heavy metals and persistent organic pollutants, on child neurodevelopment is now established, however our understanding of how these contaminants alter the human brain is very limited. To address this issue, more effort must be made to integrate brain imaging tools with epidemiological studies. In this seminar, I will be presenting EEG and MRI data collected in birth-cohort studies where impairments of cognitive and sensory functions were observed in association with prenatal exposure to mercury, lead, PCB or organophosphate insecticides. Results obtained in children and adolescents suggest that each pollutant might affect different levels of brain processing and that frontal regions are particularly vulnerable.
Sex-Specific Brain Transcriptional Signatures in Human MDD and their Correlates in Mouse Models of Depression
Major depressive disorder (MDD) is a sexually dimorphic disease. This sexual dimorphism is believed to result from sex-specific molecular alterations affecting functional pathways regulating the capacity of men and women to cope with daily life stress differently. Transcriptional changes associated with epigenetic alterations have been observed in the brain of men and women with depression and similar changes have been reported in different animal models of stress-induced depressive-like behaviors. In fact, most of our knowledge of the biological basis of MDD is derived from studies of chronic stress models in rodents. However, while these models capture certain aspects of the features of MDD, the extent to which they reproduce the molecular pathology of the human syndrome remains unknown and the functional consequences of these changes on the neuronal networks controlling stress responses are poorly understood. During this presentation, we will first address the extent by which transcriptional signatures associated with MDD compares in men and women. We will then transition to the capacity of different mouse models of chronic stress to recapitulate some of the transcriptional alterations associated with the expression of MDD in both sexes. Finally, we will briefly elaborate on the functional consequences of these changes at the neuronal level and conclude with an integrative perspective on the contribution of sex-specific transcriptional profiles on the expression of stress responses and MDD in men and women.
How talking stands on posture
Progenitor mechanisms and cerebral cortical malformations'
Does the brain have a sex? Role of gonadal hormones
Programmed Axon Death and its Roles in Human Disease
Axons degenerate before the neuronal soma in many neurodegenerative diseases. Programmed axon death (Wallerian degeneration) is a widely-occurring mechanism of axon loss that is well understood and preventable in animals. Its aberrant activation by mutation of the pro-survival gene Nmnat2 directly causes axonopathy in mice with severity ranging from mild polyneuropathy to perinatal lethality. Rare biallelic mutations in the homologous human gene cause related phenotypes in patients. NMNAT2 is a negative regulator of the prodegenerative NADase SARM1. Constitutive activation of SARM1 is cytotoxic and the human SARM1 locus is significantly associated with sporadic ALS. Another negative regulator, STMN2, has also been implicated in ALS, where it is commonly depleted downstream of TDP-43. In mice, programmed axon death can be robustly blocked by deletion of Sarm1, or by overexpression, axonal targeting and/or stabilization of various NMNAT isoforms. This alleviates models of many human disorders including some forms of peripheral neuropathy, motor neuron diseases, glaucoma, Parkinson’s disease and traumatic brain injury, and it confers lifelong rescue on the lethal Nmnat2 null phenotype and other conditions. Drug discovery programs now aim to achieve similar outcomes in human disease. In order to optimize the use of such drugs, we have characterized a range of human NMNAT2 and SARM1 functional variants that underlie a spectrum of axon vulnerability in the human population. Individuals at the vulnerable end of this spectrum are those most likely to benefit from drugs blocking programmed axon death, and disorders associated with these genotypes are promising indications in which to apply them.
Carnosine negatively modulates pro-oxidant activities of M1 peripheral macrophages and prevents neuroinflammation induced by amyloid-β in microglial cells
Carnosine is a natural dipeptide widely distributed in mammalian tissues and exists at particularly high concentrations in skeletal and cardiac muscles and brain. A growing body of evidence shows that carnosine is involved in many cellular defense mechanisms against oxidative stress, including inhibition of amyloid-β (Aβ) aggregation, modulation of nitric oxide (NO) metabolism, and scavenging both reactive nitrogen and oxygen species. Different types of cells are involved in the innate immune response, with macrophage cells representing those primarily activated, especially under different diseases characterized by oxidative stress and systemic inflammation such as depression and cardiovascular disorders. Microglia, the tissue-resident macrophages of the brain, are emerging as a central player in regulating key pathways in central nervous system inflammation; with specific regard to Alzheimer’s disease (AD) these cells exert a dual role: on one hand promoting the clearance of Aβ via phagocytosis, on the other hand increasing neuroinflammation through the secretion of inflammatory mediators and free radicals. The activity of carnosine was tested in an in vitro model of macrophage activation (M1) (RAW 264.7 cells stimulated with LPS + IFN-γ) and in a well-validated model of Aβ-induced neuroinflammation (BV-2 microglia treated with Aβ oligomers). An ample set of techniques/assays including MTT assay, trypan blue exclusion test, high performance liquid chromatography, high-throughput real-time PCR, western blot, atomic force microscopy, microchip electrophoresis coupled to laser-induced fluorescence, and ELISA aimed to evaluate the antioxidant and anti-inflammatory activities of carnosine was employed. In our experimental model of macrophage activation (M1), therapeutic concentrations of carnosine exerted the following effects: 1) an increased degradation rate of NO into its non-toxic end-products nitrite and nitrate; 2) the amelioration of the macrophage energy state, by restoring nucleoside triphosphates and counterbalancing the changes in ATP/ADP, NAD+/NADH and NADP+/NADPH ratio obtained by LPS + IFN-γ induction; 3) a reduced expression of pro-oxidant enzymes (NADPH oxidase, Cyclooxygenase-2) and of the lipid peroxidation product malondialdehyde; 4) the rescue of antioxidant enzymes expression (Glutathione peroxidase 1, Superoxide dismutase 2, Catalase); 5) an increased synthesis of transforming growth factor-β1 (TGF-β1) combined with the negative modulation of interleukines 1β and 6 (IL-1β and IL-6), and 6) the induction of nuclear factor erythroid-derived 2-like 2 (Nrf2) and heme oxygenase-1 (HO-1). In our experimental model of Aβ-induced neuroinflammation, carnosine: 1) prevented cell death in BV-2 cells challenged with Aβ oligomers; 2) lowered oxidative stress by decreasing the expression of inducible nitric oxide synthase and NADPH oxidase, and the concentrations of nitric oxide and superoxide anion; 3) decreased the secretion of pro-inflammatory cytokines such as IL-1β simultaneously rescuing IL-10 levels and increasing the expression and the release of TGF-β1; 4) prevented Aβ-induced neurodegeneration in primary mixed neuronal cultures challenged with Aβ oligomers and these neuroprotective effects was completely abolished by SB431542, a selective inhibitor of type-1 TGF-β receptor. Overall, our data suggest a novel multimodal mechanism of action of carnosine underlying its protective effects in macrophages and microglia and the therapeutic potential of this dipeptide in counteracting pro-oxidant and pro-inflammatory phenomena observed in different disorders characterized by elevated levels of oxidative stress and inflammation such as depression, cardiovascular disorders, and Alzheimer’s disease.
Dynamics of microbiota communities during physical perturbation
The consortium of microbes living in and on our bodies is intimately connected with human biology and deeply influenced by physical forces. Despite incredible gains in describing this community, and emerging knowledge of the mechanisms linking it to human health, understanding the basic physical properties and responses of this ecosystem has been comparatively neglected. Most diseases have significant physical effects on the gut; diarrhea alters osmolality, fever and cancer increase temperature, and bowel diseases affect pH. Furthermore, the gut itself is comprised of localized niches that differ significantly in their physical environment, and are inhabited by different commensal microbes. Understanding the impact of common physical factors is necessary for engineering robust microbiota members and communities; however, our knowledge of how they affect the gut ecosystem is poor. We are investigating how changes in osmolality affect the host and the microbial community and lead to mechanical shifts in the cellular environment. Osmotic perturbation is extremely prevalent in humans, caused by the use of laxatives, lactose intolerance, or celiac disease. In our studies we monitored osmotic shock to the microbiota using a comprehensive and novel approach, which combined in vivo experiments to imaging, physical measurements, computational analysis and highly controlled microfluidic experiments. By bridging several disciplines, we developed a mechanistic understanding of the processes involved in osmotic diarrhea, linking single-cell biophysical changes to large-scale community dynamics. Our results indicate that physical perturbations can profoundly and permanently change the competitive and ecological landscape of the gut, and affect the cell wall of bacteria differentially, depending on their mechanical characteristics.
Robotic mapping and generative modelling of cytokine response
We have developed a robotic platform allowing us to monitor cytokines dynamics (including IL-2, IFN-g, TNF, IL-6) of immune cells in vitro, with unprecedented resolution. To understand the complex emerging dynamics, we use interpretable machine learning techniques to build a generative model of cytokine response. We discover that, surprisingly, immune activity is encoded into one global parameter, encoding ligand antigenic properties and to a less extent ligand quantity. Based on this we build a simple interpretable model which can fully explain the broad variability of cytokines dynamics. We validate our approach using different lines of cells and different ligands. Two processes are identified, connected to timing and intensity of cytokine response, which we successfully modulate using drugs or by changing conditions such as initial T cell numbers. Our work reveals a simple "cytokine code", which can be used to better understand immune response in different contexts including immunotherapy. More generally, it reveals how robotic platforms and machine learning can be leveraged to build and validate systems biology models.
Using Nengo and the Neural Engineering Framework to Represent Time and Space
The Neural Engineering Framework (and the associated software tool Nengo) provide a general method for converting algorithms into neural networks with an adjustable level of biological plausibility. I will give an introduction to this approach, and then focus on recent developments that have shown new insights into how brains represent time and space. This will start with the underlying mathematical formulation of ideal methods for representing continuous time and continuous space, then show how implementing these in neural networks can improve Machine Learning tasks, and finally show how the resulting systems compare to temporal and spatial representations in biological brains.
Neural Engineering: Building large-scale cognitive models of the brain
The Neural Engineering Framework has been used to create a wide variety of biologically realistic brain simulations that are capable of performing simple cognitive tasks (remembering a list, counting, etc.). This includes the largest existing functional brain model. This talk will describe this method, and show some examples of using it to take high-level cognitive algorithms and convert them into a neural network that implements those algorithms. Overall, this approach gives us new ways of thinking about how the brain works and what sorts of algorithms it is capable of performing.
Central SELENOT expression regulates gonadotrope axis function, sexual behavior, and fertility in male and female mice
FENS Forum 2024
Omentin-1 in the mouse hypothalamic neuronal cells: Expression and effect on the regulation of gonadotropin-releasing hormone expression and secretion, viability, and apoptosis in GT1-7 cells
FENS Forum 2024
Src-NADH dehydrogenase subunit 2 complex and recognition memory of imprinting in domestic chicks
FENS Forum 2024